Bioventus (BVS) Accounts Payables (2020 - 2026)
Bioventus' (BVS) quarterly Accounts Payables came in at $24.0 million in Q1 2026, up 25.28% YoY from $19.2 million in Q1 2025, and up 120.08% on a QoQ basis from $10.9 million in Q4 2025.
Bioventus (BVS) Accounts Payables (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Accounts Payables data on file, last reported at $24.0 million in Q1 2026.
- Quarterly Accounts Payables rose 25.28% year-over-year to $24.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.0 million (up 25.28% YoY) and the FY2025 annual result came in at $10.9 million, down 53.87% from the prior year.
- Accounts Payables grew to $24.0 million in Q1 2026, from $10.9 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $41.4 million in Q3 2023 to a low of $10.9 million in Q4 2025.
- A 5-year average of $24.0 million and a median of $23.7 million in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables surged 160.45% — and 2025, when it plunged 53.87%.
- Tracing BVS's Accounts Payables over 5 years: stood at $36.7 million in 2022, then slumped by 37.22% to $23.0 million in 2023, then advanced by 2.83% to $23.7 million in 2024, then sank by 53.87% to $10.9 million in 2025, then surged by 120.08% to $24.0 million in 2026.
- The last three Accounts Payables figures came in at $24.0 million (Q1 2026), $10.9 million (Q4 2025), and $26.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 2.42 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 344.10 Mn |
| 10 | Bioventus | 968.49 Mn | 939.04 Mn | 105.67 Mn | 20.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 20.20 Mn |
| Mar 28, 2026 | 24.05 Mn |
| Dec 31, 2025 | 10.93 Mn |
| Sep 27, 2025 | 26.65 Mn |
| Jun 28, 2025 | 24.25 Mn |
| Mar 29, 2025 | 19.20 Mn |
| Dec 31, 2024 | 23.69 Mn |
| Sep 28, 2024 | 16.85 Mn |
| Jun 29, 2024 | 24.44 Mn |
| Mar 30, 2024 | 19.10 Mn |
| Dec 31, 2023 | 23.04 Mn |
| Sep 30, 2023 | 17.64 Mn |
| Jul 1, 2023 | 41.36 Mn |
| Apr 1, 2023 | 32.83 Mn |
| Dec 31, 2022 | 36.70 Mn |
| Oct 1, 2022 | 19.08 Mn |
| Jul 2, 2022 | 25.74 Mn |
| Apr 2, 2022 | 22.50 Mn |
| Dec 31, 2021 | 16.92 Mn |
| Oct 2, 2021 | 10.90 Mn |